Harsch Mutya 4

What Happened

• Mutya Harsch, Chief Legal Officer and General Counsel of VYNE Therapeutics (VYNE), had 4,007 shares withheld by the company to satisfy tax withholding associated with the vesting of restricted stock units (RSUs).
• The withholding price was $0.60 per share, totaling $2,394. This was a tax-withholding disposition (code F), not an open-market sale.

Key Details

• Transaction date: 2026-03-31; Filing date: 2026-04-02 (filed within the typical reporting window).
• Shares withheld/disposed: 4,007 at $0.60 each — total value $2,394.
• Transaction code: F (shares withheld to satisfy tax withholding on vesting) — footnote confirms shares were withheld by the issuer to meet tax obligations.
• Shares owned after the transaction: not specified in the provided filing.

Context

• This was a routine tax-withholding action upon RSU vesting (sometimes called a "sell-to-cover" or withholding), where the company retains shares rather than the insider executing an open-market sale. Such transactions are administrative and do not by themselves indicate a change in the insider's view of the company.